Press Releases

Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.

ADVANZ PHARMA Partners with Veeva to Set Unified Digital-First Commercial Foundation

Wednesday, June 21, 2023

Veeva Systems NYSE VEEV today announced that ADVANZ PHARMA is standardizing commercial operations on Veeva Commercial Cloud as it expands in new markets across Europe With a complete suite of Veeva software and data ADVANZ can drive a unified field s...

Diatech Pharmacogenetics Announces New Collaboration to Advance Precision Testing in Oncology

Wednesday, June 21, 2023

Diatech Pharmacogenetics Diatech has established a collaboration agreement with Janssen Pharmaceutica NV with the aim of improving access to precision medicine for patients with bladder cancer

Simulations Plus Acquires Immunetrics to Expand its Immunology and Oncology Drug Development Capabilities

Wednesday, June 21, 2023

Simulations Plus Inc Nasdaq SLP Simulations Plus a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy today announced the acquisition of Immunetrics Inc Immunetrics a modeling and simulation compa...

Evox Therapeutics Acquires Exosome AAV Technology and Intellectual Property

Tuesday, June 20, 2023

Evox Therapeutics Ltd Evox or the Company a leading exosome therapeutics company has purchased Codiak Biosciences engExAAV technology platform including all intellectual property rights therein as well as secured exclusive access to certain engineeri...

Catalyst Pharmaceuticals to License North American Rights to Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals

Tuesday, June 20, 2023

Catalyst Pharmaceuticals Inc Catalyst Nasdaq CPRX a commercialstage biopharmaceutical company focused on inlicensing developing and commercializing novel medicines for patients living with rare diseases today announced that Catalyst has entered into...

Merck Completes Acquisition of Prometheus Biosciences, Inc.

Saturday, June 17, 2023

Merck NYSE MRK known as MSD outside of the United States and Canada today announced the completion of the Prometheus Biosciences Inc Prometheus NASDAQ RXDX acquisition Prometheus is now a whollyowned subsidiary of Merck and the common stock of Promet...

Hikma exceeds 150 injectable medicines in the US with launch of Dobutamine Injection, USP

Friday, June 16, 2023

Hikma Pharmaceuticals PLC Hikma the multinational pharmaceutical company has launched Dobutamine Injection USP in a mgmL vial in the US With this launch Hikmas growing US portfolio of sterile injectable medicines now exceeds products spanning a wide...

Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera

Friday, June 16, 2023

Confo Therapeutics a leader in the discovery of medicines targeting Gprotein coupled receptors GPCRs today announced that it has entered into a research collaboration with AbCellera for the discovery of therapeutic antibody candidates targeting two u...

Endo Launches Dexlansoprazole Capsules, Generic Version of Dexilant

Friday, June 16, 2023

Endo International plc OTC ENDPQ announced today that one of its operating companies Par Pharmaceutical Inc has begun shipping dexlansoprazole mg capsules a generic version of Takedas Dexilant This additional dosage strength rounds out the product f...

Breast Cancer Canada, AstraZeneca Canada and Illumina Join Forces to Launch Grants to Support Breast Cancer Screening and Detection

Friday, June 16, 2023

Today Breast Cancer Canada a national charity dedicated to saving lives through breast cancer research announces a new research grant in collaboration with AstraZeneca Canada a global biopharmaceutical company and Illumina a world leader in DNA se...